HYPR - NASDAQ

Hyperfine, Inc.

HYPR·NASDAQ

$1.53

+4.1%

HealthcareMedical - Devices

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$129.27M

EPS-0.4300

P/E Ratio-3.57

Earnings Date08/12/2026

55.26M

Assets

-6%

3Y-59.0%

5Y-23.0%

10Y+81.0%

14.26M

Total Liabilities

45%

3Y+38.0%

5Y+232.0%

10Y-80.0%

41.01M

Total Equity

-16%

3Y-67.0%

5Y-39.0%

10Y-203.0%

Hyperfine, Inc. Funding & Solvency Profile

HYPR · NASDAQ

Current Assets

Cash & Cash Equivalents35.09M

Net Receivables6.52M

Inventory7.09M

Other Current Assets2.21M

Total Current Assets51 M

Non-Current Assets

Property, Plant & Equipment2.55M

Goodwill & Intangible Assets0.00

Long-Term Investments734.00K

Other Non-Current Assets1.07M

Total Non-Current Assets4 M

Total Assets

55.26M

Financial Health Analysis

Current Ratio

4.34x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.35x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

39 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

92% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Hyperfine, Inc. Balance Sheet

HYPR • NASDAQ

Hyperfine, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	35.1M	37.6M	75.2M	118.2M	188.5M	62.7M	26.4M
Cash & Short-Term Investments	35.1M	37.6M	75.2M	118.2M	188.5M	62.7M	26.4M
Net Receivables	6.5M	8.3M	4.1M	3.1M	644K	174K	0.0
Accounts Receivables	6.5M	6M	3.2M	2.6M	553K	174K	0.0
Other Receivables	0.0	2.3M	942K	573K	91K	0.0	0.0
Inventory	7.1M	5.8M	6.6M	4.6M	4.3M	1.7M	0.0
Prepaids	0.0	0.0	0.0	0.0	1.2M	222K	837K
Other Current Assets	2.2M	1.9M	3M	2.7M	2.9M	3.5M	683K
Total Current Assets	50.9M	53.7M	88.9M	128.7M	197.5M	68.3M	28M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.5M	3.1M	3M	3.2M	3.8M	1.9M	489K
Long-Term Investments	734K	825K	0.0	744K	0.0	0.0	0.0
Other Non-Current Assets	1.1M	1.2M	2.3M	1.4M	1.2M	1.3M	2.1M
Total Non-Current Assets	4.4M	5.2M	5.3M	5.4M	5M	3.2M	2.6M
Total Assets	55.3M	58.9M	94.2M	134.1M	202.5M	71.5M	30.6M
LIABILITIES
CURRENT LIABILITIES
Total Payables	4.1M	1.6M	1.3M	678K	4.2M	948K	1.2M
Accounts Payable	4.1M	1.6M	1.2M	678K	2.2M	948K	1.2M
Other Payables	0.0	0.0	61K	0.0	2M	0.0	0.0
Accrued Expenses	0.0	4.9M	2.3M	4.6M	10.1M	1.4M	493K
Short Term Debt	248K	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations (Current)	0.0	269K	185K	0.0	0.0	0.0	0.0
Deferred Revenue	1.5M	1.5M	2.1M	1.4M	730K	0.0	0.0
Other Current Liabilities	5.9M	473K	2.9M	2.2M	700K	1.8M	107K
Total Current Liabilities	11.7M	8.7M	8.8M	8.8M	15.7M	4.1M	1.8M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	178K	0.0
Deferred Revenue (Non-Current)	729K	1.1M	968K	1.5M	510K	0.0	0.0
Other Non-Current Liabilities	1.7M	78K	64K	0.0	0.0	1.0	68.6M
Total Non-Current Liabilities	2.5M	1.1M	1M	1.5M	510K	178K	68.6M
Capital Lease Obligations	66K	269K	185K	0.0	0.0	0.0	0.0
Total Liabilities	14.3M	9.9M	9.8M	10.3M	16.2M	4.3M	70.4M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	128.3M	68.6M
Common Stock	10K	7K	7K	7K	7K	0.0	0.0
Additional Paid-In Capital	371M	343.5M	338.1M	333.2M	322.5M	10.4M	8.2M
Retained Earnings	-330M	-294.4M	-253.7M	-209.5M	-136.3M	-71.5M	-48M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	-68.6M
Total Stockholders' Equity	41M	49M	84.4M	123.7M	186.2M	67.2M	-39.9M
Total Equity	41M	49M	84.4M	123.7M	186.2M	67.2M	-39.9M
SUMMARY
Total Liabilities & Equity	55.3M	58.9M	94.2M	134.1M	202.5M	71.5M	30.6M
Total Investments	734K	825K	0.0	744K	0.0	0.0	0.0
Total Debt	314K	269K	185K	0.0	0.0	178K	0.0
Net Debt	-34.8M	-37.4M	-75M	-118.2M	-188.5M	-62.5M	-26.4M
Shares Outstanding	78,699,690	78,699,690	78,699,690	78,699,690	78,699,690	78,699,690	78,699,690

SEC Filings

HYPR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 21, 2026	May 21, 2026	2026	View Filing
S-3 S-3 N/A	May 12, 2026	May 12, 2026		View Filing
10-Q 10-Q 2026 Q1 Q1	May 12, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 12, 2026	May 12, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 08, 2026	May 21, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 18, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 12, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 29, 2025	December 29, 2025	2025	View Filing

Showing 1 to 10 of 105 filings

Related Guides

Blog Categories

Continue your HYPR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.